Skip to main content
LXEO filings

Corporate insider profile

Jose Manuel Otero Filing Activity

Latest reported as Chief Operating Officer of Lexeo Therapeutics, Inc. (LXEO).

Purchase filings
0
Reported companies
1
Net open-market value
-$6,606.35
Latest transaction
May 18, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 18, 2026Lexeo Therapeutics, Inc. (LXEO)Chief Operating OfficerSale1,302$5.07$6,606